For immunohistochemistry on paraffin sections, is it more cost-effective to use ready-to-use or concentrated primary antibodies?

Ready-to-use primary antibodies priced at 100-200 yuan/vial for routine human tumor markers can be sourced from domestic manufacturers such as Zhongshan Golden Bridge, Maixin, and GeneTech, and some small-pack sizes or promotional offers can fall within this range; imported RTUs tend to be more expensive. Be sure to ask about the volume per vial. Some ready-to-use formats are 3 mL/5 mL, with 100-200 μL applied per slide. At 60 slides per month, consumption is about 6-12 mL, so do not calculate cost only by "vial" and assume it is cheap. If the target is relatively uncommon, there will be fewer options at this price point, and you can request a trial sample for validation first.

Repair solution and blocking generally do not need to be changed just because you switch to a ready-to-use format, because repair conditions mainly depend on the antigen epitope and antibody clone, not the formulation. However, after changing brands or clones, you must redo gradient testing for heat-induced repair and blocking solution. Ready-to-use primary antibodies are usually developed according to the manufacturer's matched detection system. If you continue to use your original universal secondary antibody, it is recommended to perform small-sample compatibility validation. If using the same clone in a different formulation, the repair conditions can be retained, but you should also run a positive control to confirm.

Batch-to-batch variability in staining intensity is often not a problem with the concentrated format itself, but rather with diluent pH, manual pipetting error, antibody freeze-thaw cycles, or drift in retrieval conditions. Switching to a ready-to-use format can reduce the dilution step, but it cannot solve retrieval and blocking issues. It is recommended to first establish a fixed batch of control tissue microarrays, and each time a new antibody lot is opened, perform parallel staining with the previous lot to compare signal intensity and background; at the same time, strictly prepare the retrieval solution according to the instructions and record pH and temperature. In this way, both concentrated and ready-to-use formats can be more stable.

During the transition period, it is recommended to first purchase 1-2 vials of ready-to-use staining reagent for archived sections, while using the same lot of your current concentrated reagent as a control. If the ready-to-use reagent shows stronger signal, lower background, and better scoring consistency under the same conditions, then gradually switch over. When purchasing, have the distributor ship in monthly batches to avoid exceeding the 1-3 month shelf life after opening. Do not expect that "switching to ready-to-use will guarantee stability" — stability still requires control sections, a fixed SOP, and regular calibration and repair of the equipment.

For 60 slides per month, the actual cost of concentrated type may be lower, but dilution errors, variability between different operators, repeated waste, and quality control slides must be factored in; ready-to-use type has a higher unit price, but eliminates the dilution step and should be used up as soon as possible after opening. You can compare: if one vial of concentrated type can make several hundred slides while you only do 60 slides per month, the shelf life after opening and repeated retrieval may instead become risks; small-pack ready-to-use type may be more suitable for laboratories with low volume and a need for stability. It is recommended not to look only at the list price, but to calculate by the actual cost per slide.